Value assessment of new interventions for Alzheimer’s disease dementia in Japan based on literature review and group interview

References

• Dementia [Internet]. Geneva (Switzerland): World Health Organization; 2021 [cited 2022 Mar 11]. Available from: https://www.who.int/news-room/fact-sheets/detail/dementia
   Google Scholar
• Ninomiya T Research on future projection of the population of the elderly with dementia in Japan. Tokyo (Japan): Ministry of Health, Labour and Welfare; 2015. Japanese.
   Google Scholar
• Asada T. Prevalence of dementia in urban areas and functional disability in dementia. Tokyo (Japan):Ministry of Health, Labour and Welfare;2013. Japanese.
   Google Scholar
• Jack CR, Knopman DS, Jagust WJ, et al. Tracking pathophysiological processes in Alzheimer’s disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol. 2013;12(2):207–216.
   PubMed Web of Science ®Google Scholar
• Scheltens P, Blennow K, Breteler MM, et al. Alzheimer’s disease. Lancet. 2016;388(10043):505–517.
   PubMed Web of Science ®Google Scholar
• Karran E, De Strooper B. The amyloid hypothesis in Alzheimer disease: new insights from new therapeutics. Nat Rev Drug Discov. 2022;21(4):306–318.
   PubMed Web of Science ®Google Scholar
• Dementia Clinical Practice Guideline Development Committee. Clinical practice guideline for dementia; 2017. Tokyo (Japan): Igaku-Shoin; 2017. Japanese.
   Google Scholar
• Livingston G, Sommerlad A, Orgeta V, et al. Dementia prevention, intervention, and care. Lancet. 2017;390(10113):2673–2734.
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Care Excellence. NICE guideline. Dementia: assessment, management and support for people living with dementia and their carers. NICE guideline [NG97] . London (UK); 2018 .
   Google Scholar
• Birks JS, Harvey RJ. Donepezil for dementia due to Alzheimer’s disease. Cochrane Database Syst Rev. 2018;6. CD001190.
   PubMed Web of Science ®Google Scholar
• Grossberg GT, Tong G, Burke AD, et al. Present algorithms and future treatments for Alzheimer’s disease. J Alzheimers Dis. 2019;67(4):1157–1171.
   PubMed Web of Science ®Google Scholar
• Center for Outcomes Research and Economic Evaluation for Health, National Institute of Public Health. Guideline for preparing cost-effectiveness evaluation to the central social insurance medical council. version 2.0. Tokyo (Japan); 2019.
   Google Scholar
• National Institute for Health and Care Excellence. Guide to the methods of technology appraisal 2013. Process and Methods [PMG9]. London (UK); 2013.
   Google Scholar
• Cost-effectiveness, the QALY, and the evLYG [Internet]. Boston(US): Institute for Clinical and Economic Review; [cited 2022 Mar 11]. Available from: https://icer.org/our-approach/methods-process/cost-effectiveness-the-qaly-and-the-evlyg/.
   Google Scholar
• Vurgun N, Hubscher E, Sandman K. Time to care: the importance of caregiver voice in healthcare, drug development, and value assessment. Value Outcomes Spotlight. 2021;7(4):28–30.
   Google Scholar
• Devlin N, Parkin D, Janssen B. An introduction to EQ-5D instruments and their applications. In: Methods for analysing and reporting EQ-5D data. Cham: Springer; 2020. p. 1–22.
   Google Scholar
• Logsdon RG, Gibbons LE, McCurry SM, et al. Quality of life in Alzheimer’s disease: patient and caregiver reports. J Ment Health Aging. 1999;5(1):21–32
   Google Scholar
• Matsui T, Nakaaki S, Murata Y, et al. Determinants of the quality of life in Alzheimer’s disease patients as assessed by the Japanese version of the quality of Life-Alzheimer’s disease scale. Dement Geriatr Cogn Disord. 2006;21(3):182–191.
   PubMed Web of Science ®Google Scholar
• Zarit SH, Reever KE, Bach-Peterson J. Relatives of the impaired elderly: correlates of feelings of burden. Gerontologist. 1980;20(6):649–655.
   PubMed Web of Science ®Google Scholar
• Arai Y, Tamiya N, Yano E. The short version of the Japanese version of the Zarit Caregiver Burden Interview (J-ZBI_8): its reliability and validity. Jpn J Geriat. 2003;40(5):497–503. Japanese.
   PubMedGoogle Scholar
• Matsumoto N, Ikeda M, Fukuhara R, et al. Validity and reliability of the Japanese version of the Neuropsychiatric Inventory Caregiver Distress Scale (NPI D) and the Neuropsychiatric Inventory Brief Questionnaire Form (NPI-Q). No To Shinkei. 2006;58(9):785–790. Japanese.
   PubMedGoogle Scholar
• Ashizawa T, Igarashi A, Sakata Y, et al. Impact of the severity of Alzheimer’s disease on the quality of life, activities of daily living, and caregiving costs for institutionalized patients on anti-Alzheimer medications in Japan. J Alzheimers Dis. 2021;81(1):367–374.
   PubMed Web of Science ®Google Scholar
• Hachimori A, Kawano Y, Honma A, et al. Changes in the comprehensive-health-related QOL of patients with dementia of Alzheimer type (DAT) treated with donepezil and their primary caregivers. Jpn J Geriatr Psychiatr. 2009;20(9):997–1008. Japanese. ••of considerable interest. Patient QOL and caregiver QOL are reported.
   Google Scholar
• Yasuda A, Kawano Y, Kinoshita T, et al. Changes in the comprehensive-health-related QOL of persons with dementia of the Alzheimer type (DAT) treated with donepezil and their primary carers. Jpn J Geriatr Psychiatr. 2011;22(12):1433–1445. Japanese.
   Google Scholar
• Ikeda S, Mimura M, Ikeda M, et al. Economic burden of Alzheimer’s disease dementia in Japan. J Alzheimers Dis. 2021;81(1):309–319.
   PubMed Web of Science ®Google Scholar
• Nakanishi M, Igarashi A, Ueda K, et al. Costs and resource use of community-dwelling patients with Alzheimer’s disease in Japan: 18-month results from the GERAS-J study. Curr Med Res Opin. 2021;37(8):1331–1339.
   PubMed Web of Science ®Google Scholar
• Fukuda H, Ono R, Maeda M, et al. Medical care and long-term care expenditures attributable to Alzheimer’s disease onset: results from the LIFE study. J Alzheimers Dis. 2021;84(2):807–817.
   PubMed Web of Science ®Google Scholar
• Sado M, Ninomiya A, Shikimoto R, et al. The estimated cost of dementia in Japan, the most aged society in the world. Plos One. 2018;13(11):e0206508.
   PubMed Web of Science ®Google Scholar
• Basic survey on wage structure (Chingin Kozo Kihon Tokei Chosa) 2014 [Internet]. Tokyo (Japan): Ministry of Health Labour and Welfare of Japan; 2014 [cited 2022 Mar 11]. Available from: https://www.mhlw.go.jp/toukei/itiran/roudou/chingin/kouzou/z2014/index.html.
   Google Scholar
• Finkel SI, Costa Silva J, Cohen GD, et al. Behavioral and psychological symptoms of dementia: a consensus statement on current knowledge and implications for research and treatment. Am J Geriatr Psychiatry. 1998;6(2):97–100.
   Web of Science ®Google Scholar
• Bryan S, Hardyman W, Bentham P, et al. Proxy completion of EQ-5D in patients with dementia. Qual Life Res. 2005;14(1):107–118.
   PubMed Web of Science ®Google Scholar
• Byers AL, Yaffe K. Depression and risk of developing dementia. Nat Rev Neurol. 2011;7(6):323–331.
   PubMed Web of Science ®Google Scholar
• Krabbe PF, Stouthard ME, Essink-Bot ML, et al. The effect of adding a cognitive dimension to the EuroQol multiattribute health-status classification system. J Clin Epidemiol. 1999;52(4):293–301.
   PubMed Web of Science ®Google Scholar
• Wolfs CAG, Dirksen CD, Kessels A, et al. Performance of the EQ-5D and the EQ-5D+C in elderly patients with cognitive impairments. Health Qual Life Outcomes. 2007;5(1):33.
   PubMedGoogle Scholar
• Naidoo B A new instrument for consideration of a broader range of benefits for people, their families and carers. London (UK); National Institute for Health and Care Excellence; 2021 [cited 2022 Mar 11]. Available from: https://www.nice.org.uk/news/blog/a-new-instrument-for-consideration-of-a-broader-range-of-benefits-for-people-their-families-and-carers.
   Google Scholar
• Shibahara H, Inoue S, Kobayashi M. Handling of public long-term care costs in UK NICE technology appraisal guidance: a review in neurological conditions. J Jpn Soc Healthc Admin. 2022;59(1):2–10. Japanese.
   Google Scholar
• Lin GA, Whittington MD, Synnott PG, et al. Aducanumab for Alzheimer’s disease: effectiveness and value. Final evidence report and meeting summary. 2021. Boston (US): Institute for Clinical and Economic Review; 2021.
   Google Scholar
• Fengler AP, Goodrich N. Wives of elderly disabled men: the hidden patients. Gerontologist. 1979;19(2):175–183.
   PubMed Web of Science ®Google Scholar
• George LK, Gwyther LP. Caregiver well-being: a multidimensional examination of family caregivers of demented adults. Gerontologist. 1986;26(3):253–259.
   PubMed Web of Science ®Google Scholar
• Pedersini R, Annunziata K Cross-country profile of adult caregivers. Poster session presented at: ISPOR 18th Annual Eur Congress; 2015 Nov 7−11; Milan (Italy).
   Google Scholar
• Pennington BM. Inclusion of carer health-related quality of life in National Institute for Health and Care Excellence appraisals. Value Health. 2020;23(10):1349–1357.
   PubMed Web of Science ®Google Scholar
• Dow J, Robinson J, Robalino S, et al. How best to assess quality of life in informal carers of people with dementia; A systematic review of existing outcome measures. Plos One. 2018;13(3):e0193398.
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Care Excellence. Highly specialised technologies guidance (HST9). Inotersen for treating hereditary transthyretin amyloidosis; 2019.
   Google Scholar
• Annual report on the ageing society [Summary] FY2021. Tokyo (Japan); Cabinet Office Japan; 2021 [cited 2022 May 21]. Available from: https://www8.cao.go.jp/kourei/english/annualreport/2021/pdf/2021.pdf.
   Google Scholar